Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300399
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,202
Award facts
- Contract value 50% obligated
-
- $3,201.68 Current, with exercised options
- $6,403.36 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
About this award
Lonza Walkersville, Inc., a foreign-owned manufacturer of biological materials and laboratory equipment based in Walkersville, Maryland, was awarded a Blanket Purchase Agreement (BPA) call valued at $6,403.36 for drugs and biologicals on February 19, 2014, with a completion date of December 31, 2014. This contract was procured through open competition with no set-aside designation and is funded by the Office of the Director within a civilian federal agency. As a subsidiary of the global Lonza Group, the company specializes in providing high-precision biological research products and scientific services essential to federal research institutions.
This award is a call against Lonza Walkersville's broader single-award BPA with the HHS Office of Logistics and Acquisition Operations, valued at $10 million through December 31, 2025. The BPA enables streamlined procurement of biological materials, blood products, media, laboratory supplies, and scientific equipment to support the National Institutes of Health institutes and research centers. Lonza Walkersville has established itself as a critical supplier to federal agencies including NIH, FDA, and the Department of Veterans Affairs, providing specialized research equipment and materials that support critical research across cancer studies, infectious diseases, regenerative medicine, and cellular engineering initiatives.
Quick answers
Who was awarded contract HHSN26300399?
HHSN26300399 was awarded to Lonza Walkersville, Inc. by Office of the Director (National Institutes of Health) on February 19, 2014.
How much is contract HHSN26300399 worth?
The government has obligated $3,202 on HHSN26300399. Its potential value, with all options, is $6,403.
Is contract HHSN26300399 an order under another contract?
Yes. HHSN26300399 is a BPA call under HHSN263199900049886B, a blanket purchase agreement.
Was contract HHSN26300399 competed?
The extent of competition for HHSN26300399 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award